Datos a fecha 30/04/26 13:55
| Ticker | GILD |
|---|---|
| ISIN | US3755581036 |
| Sector | Atención sanitaria |
| Industria | Drug Manufacturers - General |
| Mercado | NASDAQ |
| Capitalización | $159.918.784.800 |
| Beta | 0,4 |
| Último dividendo | US$ 3,1900 |
| Sitio web | https://www.gilead.com |
| CEO | Daniel O'Day |
| Fecha de IPO | 22/01/1992 |
| País | US |
| Dirección | 333 Lakeside Drive, Foster City, CA, 94404 |
| Volumen | 4.922.639 |
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of...
El precio actual de Gilead Sciences (GILD) es de 131,66, con una variación del 2.19%.
Gilead Sciences opera en el sector Healthcare, industria Drug Manufacturers - General.
Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.
Compara brokers para acciones